Featured Speakers

  • Opening Remarks

    George Q. Daley
    Dean of the Faculty of Medicine
    Harvard University

  • Keynote

    Peter Marks
    Director of the Center for Biologics Evaluation and Research
    Food and Drug Administration
    Facilitating the Development and Availability of COVID-19 Vaccines

  • Panel Session 1: SARS-CoV-2 Vaccination: Initial Success and Future Directions

  • Moderators

    Galit Alter
    Vice President of Immunology
    Moderna

    Dan Barouch
    Director of the Center for Virology and Vaccine Research
    Beth Israel Deaconess Medical Center

  • Panelists

    William Hanage
    Associate Professor of Epidemiology
    Harvard T.H. Chan School of Public Health
    Variants and cross-reactivity

    Ai-ris Collier
    Assistant Professor of Obstetrics, Gynecology and Reproductive Biology
    Beth Israel Deaconess Medical Center
    Durability and waning immunity

    Duane Wesemann
    Associate Professor of Medicine
    Brigham and Women’s Hospital
    Immunologic imprinting and boosting

    Bisola Ojikutu
    Executive Director of the Boston Public Health Commission (BPHC)
    Vaccine global equity, vaccine hesitancy

  • Panel Session II: COVID-19 Pathogenesis and Treatment

  • Moderators

    Kate Fitzgerald
    Professor and Vice Chair, Department of Medicine,
    UMASS Medical School

    Manish Sagar
    Professor of Medicine
    Boston University School of Medicine

  • Panelists

    Jonathan Li
    Associate Professor of Medicine
    Brigham and Women’s Hospital
    Therapeutics

    Lael Yonker
    Assistant Professor of Pediatrics
    Massachusetts General Hospital
    Critical issues for kids

    Bruce Levy
    Parker B. Francis Professor of Medicine
    Brigham and Women’s Hospital
    Long COVID

    Lindsey Baden
    Professor of Medicine
    Brigham and Women’s Hospital
    What have we learned/or not about pandemics

  • Panel Session III: Preparing for SARS-CoV-2 Variants and Other Emerging Pathogens

  • Moderators

    Amy Barczak
    Assistant Professor of Medicine
    Massachusetts General Hospital

    Jeremy Luban
    Professor, Program in Molecular Medicine, Biochemistry & Molecular Biotechnology
    UMass Medical School

  • Panelists

    Katherine Siddle
    Research Scientist
    Broad Institute of MIT and Harvard
    Domestic and international monitoring of variants

    Jonathan Abraham
    Assistant Professor of Microbiology
    Harvard Medical School
    Limits of SARS-CoV-2 evolution

    John Connor
    Associate Professor of Microbiology
    Boston University
    Monkeypox and other viruses

    Jacob Lemieux
    Assistant Professor of Medicine
    Massachusetts General Hospital
    Pathogens to focus on for the future

  • Closing Remarks

    Arlene Sharpe
    George Fabyan Professor of Comparative Pathology
    Harvard Medical School

    Bruce Walker
    Director
    Ragon Institute of MGH, MIT, and Harvard